Evidence map›Paper›PMID 34024542›Full record

ArticleClinical nutrition ESPEN2021

Poor nutritional status, risk of sarcopenia and nutrition related complaints are prevalent in COVID-19 patients during and after hospital admission.

Nicolette J Wierdsma, Hinke M Kruizenga, Lotte Aml Konings, Daphne Krebbers, Jolein Rmc Jorissen, Marie-Helene I Joosten, Loes H van Aken, Flora M Tan, Ad A van Bodegraven, Maarten R Soeters and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical nutrition ESPEN, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 4 pooled it
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 4 syntheses or guidelines pooled it, 107 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Treatment of COVID-19 olfactory dysfunction with olfactory training, palmitoylethanolamide with luteolin, or combined therapy: a blinded controlled multicenter randomized trial.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2023
    Trial
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Review
  12. Article
  13. Review
  14. Observational
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Nicolette J WierdsmaDepartment of Nutrition & Dietetics, Amsterdam University Medical Centers, Amsterdam, the Netherlands. Electronic address: n.wierdsma@amsterdamumc.nl.
Hinke M KruizengaDepartment of Nutrition & Dietetics, Amsterdam University Medical Centers, Amsterdam, the Netherlands. Electronic address: h.kruizenga@amsterdamumc.nl.
Lotte Aml KoningsWageningen University and Research Center, Wageningen, the Netherlands. Electronic address: lotte.konings@wur.nl.
Daphne KrebbersDepartment of Dietetics, Franciscus Gasthuis & Vlietland, Rotterdam, the Netherlands. Electronic address: d.krebbers@franciscus.nl.
Jolein Rmc JorissenDepartment of Dietetics, Zuyderland Medical Center, Heerlen, Sittard-Geleen, the Netherlands. Electronic address: jo.jorissen@zuyderland.nl.
Marie-Helene I JoostenDepartment of Dietetics, Zuyderland Medical Center, Heerlen, Sittard-Geleen, the Netherlands. Electronic address: marie.joosten@zuyderland.nl.
Loes H van AkenDepartment of Nutrition & Dietetics, Amsterdam University Medical Centers, Amsterdam, the Netherlands. Electronic address: l.vanaken@amsterdamumc.nl.
Flora M TanDepartment of Nutrition & Dietetics, Amsterdam University Medical Centers, Amsterdam, the Netherlands. Electronic address: f.m.tan@amsterdamumc.nl.
Ad A van BodegravenDepartment of Gastroenterology, Zuyderland Medical Center, Heerlen, Sittard-Geleen, the Netherlands. Electronic address: a.vanbodegraven@zuyderland.nl.
Maarten R SoetersDepartment of Endocrinology & Metabolism, Internal Medicine, Amsterdam University Medical Centers, Amsterdam, the Netherlands. Electronic address: m.r.soeters@amsterdamumc.nl.
Peter Jm WeijsDepartment of Nutrition & Dietetics, Amsterdam University Medical Centers, AMS Research Institute, VU University, Amsterdam, the Netherlands. Electronic address: p.weijs@amsterdamumc.nl.
Amsterdam University Medical Centers · NLZuyderland Medisch Centrum · NLSint Franciscus Gasthuis · NLWageningen University & Research · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsPatients with COVID-19 infection presents with a broad clinical spectrum of symptoms and complications. As a consequence nutritional requirements are not met, resulting in weight- and muscle loss, and malnutrition. The aim of the present study is to delineate nutritional complaints, the (course of the) nutritional status and risk of sarcopenia of COVID-19 patients, during hospitalisation and after discharge.

methodsIn this prospective observational study in 407 hospital admitted COVID-19 patients in four university and peripheral hospitals, data were collected during dietetic consultations. Presence of nutrition related complaints (decreased appetite, loss of smell, changed taste, loss of taste, chewing and swallowing problems, nausea, vomiting, feeling of being full, stool frequency and consistency, gastric retention, need for help with food intake due to weakness and shortness of breath and nutritional status (weight loss, BMI, risk of sarcopenia with SARC-F ≥4 points) before, during hospital stay and after discharge were, where possible, collected.

resultsIncluded patients were most men (69%), median age of 64.8 ± 12.4 years, 60% were admitted to ICU at any time point during hospitalisation with a median LOS of 15 days and an in-hospital mortality rate of 21%. The most commonly reported complaints were: decreased appetite (58%), feeling of being full (49%) and shortness of breath (43%). One in three patients experienced changed taste, loss of taste and/or loss of smell. Prior to hospital admission, 67% of the patients was overweight (BMI >25 kg/m

conclusionIn conclusion, one in five hospital admitted COVID-19 patients suffered from serious acute weight loss and 73% had a high risk of sarcopenia. Moreover, almost all patients had one or more nutritional complaints. Of these complaints, decreased appetite, feeling of being full, shortness of breath and changed taste and loss of taste were the most predominant nutrition related complaints. These symptoms have serious repercussions on nutritional status. Although nutritional complaints persisted a long time after discharge, only a small group of patients received dietetic treatment after hospital discharge in recovery phase. Clinicians should consider the risks of acute malnutrition and sarcopenia in COVID-19 patients and investigate multidisciplinary treatment including dietetics during hospital stay and after discharge.

Indexed as

HospitalizationNutritional StatusWeight LossAdultAgedAppetiteCOVID-19FemaleHospitalsHumansLength of StayMaleMalnutritionMiddle AgedNutrition AssessmentObesityAnorexiaCOVID-19DietitianICUNutritional statusSarcopenia

Identifiers

PMID34024542
PMCPMC8056328
OpenAlexW3152585178

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.